글로벌 페이지트병 치료 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 페이지트병 치료 시장

파젯병 치료 시장은 2021년에서 2028년까지의 예측 기간 동안 3.25%의 잠재적 시장 성장률을 기록할 것으로 예상됩니다. 노령 인구의 증가는 파젯병 치료 시장 성장을 가속화하는 중요한 요인입니다.

파젯병은 뼈에서 오래된 물질을 제거하여 뼈를 리모델링하는 정상적인 기능이 상실되는 질병으로 정의됩니다. 파젯병은 명확한 증상이 없으며 파젯병을 앓고 있는 개인은 종종 알지 못합니다. 파젯병 치료는 영향을 받은 다리, 두개골, 뼈, 척추 또는 골반에 사용되며 엑스레이는 질병의 진단으로 사용됩니다.

질병에 대한 정부 인식 프로그램 의 증가는 시장 성장을 촉진할 것이며, 질병 유병률의 증가, 미국의 의료비 부담 가능성의 증가, 사람들의 지식과 인식의 증가는 페이젯병 치료 시장 성장을 주도하는 다른 요인들 중에서도 중요한 요인입니다. 게다가, 시장에서의 연구 개발 활동의 증가와 신흥 경제권의 수요 증가는 2021-2028년 예측 기간 동안 페이젯병 치료 시장에 새로운 기회를 더욱 창출할 것입니다.

그러나 시장에서의 연구 개발 비용의 상승은 다른 제약 요소 중에서도 주요 요인으로 작용하여 위에서 언급한 예측 기간 동안 파젯병 치료 시장에 더욱 어려움을 줄 것입니다.

Paget's disease treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the paget's disease treatment market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Paget's Disease Treatment Market Scope and Market Size

Paget's disease treatment market is segmented on the basis of route of administration, treatment type, distribution channel and drug-class. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of route of adminstration, paget's disease treatment market is segmented into oral, intravenous and topical.
• Based on treatment type, paget's disease treatment market is segmented into actonel, reclast, zoledronic acid, fosamax, miacalcin, aredia, calcitonin, zometa and others.
• Based on distribution channel, paget's disease treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and drug stores.
• Paget's disease treatment market is also segmented on the basis of drug-class into bisphosphonates, calcitonin analogues, calcium supplements, vitamin-D supplements and analgesics.

Paget’s Disease Treatment Market Country Level Analysis

Paget's disease treatment market is analysed and market size information is provided by country, route of administration, treatment type, distribution channel and drug-class as referenced above.

The countries covered in the paget's disease treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the paget's disease treatment market due to rise in the prevalence of the diseases, rise in the healthcare affordability in the US and rise in the knowledge and awareness amongst the people in this region. Asia-Pacific is the expected region in terms of growth in paget's disease treatment market due to increase in the geriatric population base and the increase in the awareness level among consumers regarding rare orthopedic diseases and their treatment in this region.

The country section of the paget's disease treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Paget's disease treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Paget’s Disease Treatment Market Share Analysis

Paget's disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to osteoarthritic pain management treatment.

페이지트병 치료 시장 보고서에 포함된 주요 기업으로는 Pfizer Inc., AstraZeneca, Eli Lilly and Company, Abiogen Pharma SpA, Merck Sharp & Dohme Corp., Novartis AG, GlaxoSmithKline plc., Zimmer Biomet, Johnson & Johnson Private Limited, Sun Pharmaceutical Industries Ltd, Mallinckrodt, Fresenius Kabi, Sanofi, Mylan NV 등이 있으며, 국내 및 글로벌 기업도 있습니다. 페이지트병 치료 시장 점유율 데이터는 글로벌, 북미, 남미, 유럽, 아시아 태평양(APAC) 및 중동 및 아프리카(MEA)에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-63090